Advertisement
Study first to compare rates for mRCC medical oncology
Gene signatures differentiate clinical response
Identifying low and high risk of recurrence
New mRCC medication regimen effective and well tolerated
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Standard of care is changing and may lead to better clinical outcomes
Positive results point to a better prognosis for intractable disease
Study examines concordance between commercially available genomic tests
Doctors will analyze whether survival improves
State of the Science Summit on May 18
Survival for months or several years while delaying treatment is possible
Advertisement
Advertisement